NCT06840483
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06840483
Title Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors BicycleTx Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | BEL | AUS

Facility Status City State Zip Country Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (SKCCC) Baltimore Maryland 21287 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Siteman Cancer Center St Louis Missouri 63108 United States Details
Memorial Sloan Kettering Cancer Center - Main Campus New York New York 10065 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Compass Oncology - Rose Quarter Cancer Center Portland Oregon 97227 United States Details
Texas Oncology San Antonio San Antonio Texas 78240 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
UZ Leuven Leuven 3000 Belgium Details
Oncopole Claudius Regaud Toulouse 31059 France Details
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRCCS IRST Meldola Forli/Cesena 47014 Italy Details
Clinica Oncologica-Azienda Ospedaliero Universitaria delle Marche Ancona 60126 Italy Details
Istituto Europeo di Oncologia Milan 20141 Italy Details
Hospital Quironsalud Barcelona Barcelona 08023 Spain Details
Hospital Beata Maria Ana Madrid 28007 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
The Royal Marsden NHS Foundation Trust London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field